Long

SBFM - Sunshine Biopharma Doing BIG Things!

Updated
Always DYOR and understand the dynamics of these OTC stocks (known for pump & dump) but the fundamentals here are what will ultimately drive Sunshine Biopharma to return to it's formerly glorious highs but for now, it's relegated to the fractional levels that we see. On it's face, it looks like a no-brainer . . company shedding debt, increasing earnings (still no real profitability) BUT, a recent patent publication and a litany of amazing solutions in the areas of drug-resistant cancers, COVID-19, etc. But don't take my word for it . . check it out . .

sunshinebiopharma.com/press-release-archives/

Caveat Emptor - The evil corporate empire will probably try to keep this one squashed and on the DL with massive shorting (if I had to guess) and for several reasons

1. Competition
2. Cancer is big business and people that cure it tend to go away quickly
3. Keep the price low with the help of WS peckerwoods for a cheaper acquisition

Again, I don't render professional investment advice, I just read charts and try to tie the fundamentals into a more complete picture. The Fib channel looks attractive in an uptrend, we just got a nice bump up above the 50/200 EMA and we know what kind of price history this beauty has so it's worth an add. I've got a DCA bag and will LTBH it for either a buyout or until the WS woods drive it to zero, whatever the outcome . . no risk, no reward.

Good luck!
Trade active
Gonna just drop this for ya. The lower Fib channel can always break down BUT, it's probably worth holding LTBH even if goes south. I'd take 50% at the target and then see how it fares from there. snapshot
Trade active
Looks like SBFM is now SBFMD and is headed to the Nasdaq. They reverse split the stock 1/200 so it's now trading around $8.88 and has good upside potential even if they are planning another offering. Good luck my dudes!
Trade active
These people suck . . snapshot
biotechcancerstockscoronavirusstockscovid19stockTechnical Indicatorsjohnson_and_johnsonMoving AveragesTrend Analysis

Disclaimer